On this episode of Fortune’s Leadership Next podcast, host Diane Brady talks to Eli Lilly chair and CEO Dave Ricks. They ...
Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...
BioCrossroads has named Eli Lilly CEO, Dave Ricks, the recipient of the 2024 August M. Watanabe Life Sciences Champion of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback